חזרה לתוצאות החיפוש

A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1, PHASE2

מצבים רפואיים

GIST

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • University of Southern California - Norris Comprehensive Cancer Center, Los Angeles, California, United States

    Contact: Study coordinator (Rabia Rehman) · rabia.rehman@med.usc.edu · 323-865-3000
    Contact: Principal Investigator (Syma Iqbal, MD)

  • UCLA Department of Medicine-Hematology/Oncology, Los Angeles, California, United States

    Contact: Study coordinator (Jacqueline Banuelos) · jbanuelosmurillo@mednet.ucla.edu · 310-869-7014
    Contact: Principal Investigator (Arun Singh, MD)

  • Sylvester Comprehensive Cancer Center, Miami, Florida, United States

    Contact: Study coordinator (Nailet Bestard) · nxr518@med.miami.edu · 305-243-8173
    Contact: Principal Investigator (Jonathan C Trent, MD, PhD)

  • University of Massachusetts Worcester, Worcester, Massachusetts, United States

    Contact: Study coordinator (Syliva Rollins) · Sylvia.Rollins@umassmed.edu · 7744554454

  • START Midwest, Grand Rapids, Michigan, United States

    Contact: Study coordinator (Julie Burns) · julie.burns@startmidwest.com · 616-954-5559
    Contact: Principal Investigator (Sreenivasa Chandana, M.D., Ph.D.)

  • Washington University School of Medicine - Siteman Cancer Center, St Louis, Missouri, United States

    Contact: Study coordinator (Tori Tuma) · tuma@wustl.edu · 314-747-9488
    Contact: Principal Investigator (Mia Weiss, MD)

  • Memorial Sloan Kettering Cancer Center - Main Campus, New York, New York, United States

    Contact: Study coordinator (Pragya Khadka) · khadkap1@mskcc.org
    Contact: Study coordinator (Melessa Hardayal) · hardayam@mskcc.org
    Contact: Principal Investigator (Ping Chi, MD, PhD)

  • Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States

    Contact: Study coordinator (Cancer Answer) · canceranswer@ccf.org · 216-444-7923

  • Oregon Health & Science University, Portland, Oregon, United States

    Contact: Study coordinator (Knight Cancer Institute Clinical Trials) · trials@ohsu.edu · 503-494-1080

  • Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Refiola Memushi) · Refiola.Memushi@fccc.edu · (215)-728-3564
    Contact: Principal Investigator (Margaret von Mehren, MD)

  • Virginia Cancer Specialist, PC, Fairfax, Virginia, United States

    Contact: Study coordinator (Anthony Jones) · anthony.jones@usoncology.com · 571-512-3202
    Contact: Principal Investigator (Chao Yin, MD)

  • Aarhus University Hospital, Aarhus, Denmark

    Study coordinator · ninnpede@rm.dk · +4591167534
    Contact: Principal Investigator (Ninna Aggerholm Pedersen, MD)

  • Centre Oscar Lambret, Lille, France

    Study coordinator · l-lebellec@o-lambret.fr · +1 (123) 456-7891
    Contact: Principal Investigator (Loic Lebellec, MD)

  • Institut Curie, Service d'Oncologie Médicale, Paris, France

    Study coordinator · clement.bonnet@curie.fr · 33142494217
    Contact: Principal Investigator (Clement Bonnet, MD)

  • Hôpital Européen Georges Pompidou, Paris, France

    Study coordinator · +33156092802
    Contact: Principal Investigator (Widad Lahlou, MD)

  • Universitatsklinikum Franfurt, Frankfurt, Germany

    Study coordinator · marit.ahrens@unimedizin-ffm.de · 069 6301-5677
    Contact: Principal Investigator (Marit Ahrens, MD)

  • Universitätsklinikum Eppendorf, Hamburg, Germany

    Study coordinator · j.striefler@uke.de · 0152-22824370
    Contact: Principal Investigator (Jana Striefler, MD)

  • AOU Careggi - Padiglione 16 - Piano Terra - Ambulatori Oncologici - Ufficio Trial, Florence, Italy

    Study coordinator · lorenzo.antonuzzo@unifi.it · +39 0557947298
    Contact: Principal Investigator (Lorenzo Antonuzzo, MD)

  • IRCCS Azienda Ospedaliera Metropolitana, Genova, Italy

    Study coordinator · danila.comandini@aomliguria.it · 0105553301
    Contact: Principal Investigator (Danila Comandini, MD)

  • Istituto Europeo di Oncologia, Milan, Italy

    Study coordinator · Elisabetta.setola@ieo.it · +39 02 57489438
    Contact: Principal Investigator (Elisabetta Setola, MD)

  • Antonie Van Leeuwenhoek Hospital, Amsterdam, Netherlands

    Study coordinator · +31205122103
    Contact: Principal Investigator (Neeltje Steeghs, MD)

  • Radboudumc, Nijmegen, Netherlands

    Study coordinator · +31 (0)6 3113 6977
    Contact: Principal Investigator (Ingrid Desar, MD)

  • Instituto Português de Oncologia do Porto Francisco Gentil, E.P.E., Porto, Portugal

    Study coordinator · antonio.m.abreu@ipoporto.min-saude.pt · +351 225084000
    Contact: Principal Investigator (Miguel Abreu, MD)

  • Hospital Universitario Ramón y Cajal, Madrid, Spain

    Study coordinator · mavaz4@gmail.com · +34 91 336 82 63 / 91 336 91 9
    Contact: Principal Investigator (Maria Angeles Vaz Salgado, MD)

  • Hospital Universitario Clinico San Carlos, Madrid, Spain

    Study coordinator · gloriamarquina@gmail.com · +34 91 330 30 00
    Contact: Principal Investigator (Gloria Marquina Ospina, MD)

  • Hospital Universitario Virgen Del Rocio, Seville, Spain

    Study coordinator · sanchomarquez@gmail.com · +34 955013068
    Contact: Principal Investigator (Maria Pilar Sancho Marquez, MD)

  • Inselspital Universitätsklinikum Bern, Bern, Switzerland

    Contact: Principal Investigator (Attila Kollar, MD)
מובילי המחקר

  • Clinical Team

    Study Director

    Deciphera Pharmaceuticals, LLC

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)